Patent details
EP2217603 Title: 2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 2
Basic Information
- Publication number:
- EP2217603
- PCT Application Number:
- PCT/US/2008/079439
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP088370119
- PCT Publication Number:
- WO/2009/049109
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- 2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 2
- French Title of Invention:
- FORME CRISTALLINE 2 DU 2-((R)-2-MÉTHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE
- German Title of Invention:
- KRISTALLINE FORM 2 VON 2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOL-4-CARBONSÄUREAMID
- SPC Number:
Dates
- Filing date:
- 10/10/2008
- Grant date:
- 18/11/2015
- EP Publication Date:
- 18/11/2015
- PCT Publication Date:
- 16/04/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/08/2010
- EP B1 Publication Date:
- 18/11/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 10/10/2016
- Expiration date:
- 10/10/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/10/2008
- Name:
- AbbVie Bahamas Ltd.
- Address:
- Sassoon House, Shirley Street & Victoria Avenue, New Providence, Nassau, Bahamas (BS)
Inventor
- Name:
- ZHU Guidong
- Address:
- United States (US)
Priority
- Priority Number:
- 979654 P
- Priority Date:
- 12/10/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07D 487/04;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|